Advances in next-generation sequencing and multigene panels have enabled the identification of additional moderate-risk BC genes (MBCG) that also play a role in the development of hereditary BC, such as CHEK2, ATM, RAD51C/D, and PALB2. This evidence concerns the gene CHEK2 and breast cancer.